|
| 36703796 | Facts and Perspectives: Implications of tumor glycolysis on immunotherapy response in triple negative breast cancer. | Front Oncol | 2023 |
| 37627073 | Multi-Institutional Evaluation of Pathologists' Assessment Compared to Immunoscore. | Cancers (Basel) | 2023 |
| 37620372 | Immunotherapy targeting different immune compartments in combination with radiation therapy induces regression of resistant tumors. | Nat Commun | 2023 |
| 37890930 | Pipeline to identify neoantigens exposed by radiation. | Methods Cell Biol | 2023 |
| 37608772 | Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer | J Pathol | 2023 |
| 37608771 | Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer. | J Pathol | 2023 |
| 37727740 | CD40 agonism improves anti-tumor T cell priming induced by the combination of radiation therapy plus CTLA4 inhibition and enhances tumor response. | Oncoimmunology | 2023 |
| 37418547 | The interplay between the DNA damage response and ectonucleotidases modulates tumor response to therapy. | Sci Immunol | 2023 |
| 37363104 | Updates on radiotherapy-immunotherapy combinations: Proceedings of 6<sup>th</sup> annual ImmunoRad conference. | Oncoimmunology | 2023 |
| 37199227 | Immunologically relevant effects of radiation therapy on the tumor microenvironment. | Essays Biochem | 2023 |
| 36710054 | Quantitative assessment of mitophagy in irradiated cancer cells. | Methods Cell Biol | 2023 |
| 34815266 | Something Old and Something New to Unleash the Power of Natural Killer Cells against Metastases. | Cancer Immunol Res | 2022 |
| 35405340 | Radiation therapy-induced remodeling of the tumor immune microenvironment. | Semin Cancer Biol | 2022 |
| 35672823 | Perspectives in Immunotherapy: meeting report from the Immunotherapy Bridge, December 1st-2nd, 2021. | J Transl Med | 2022 |
| 35538491 | The "Great Debate" at Melanoma Bridge 2021, December 2nd-4th, 2021. | J Transl Med | 2022 |
| 35721517 | ATM Modulates Nuclear Mechanics by Regulating Lamin A Levels. | Front Cell Dev Biol | 2022 |
| 35294260 | Expression of the mono-ADP-ribosyltransferase ART1 by tumor cells mediates immune resistance in non-small cell lung cancer. | Sci Transl Med | 2022 |
| 35017545 | Tumor infiltrating lymphocyte stratification of prognostic staging of early-stage triple negative breast cancer. | NPJ Breast Cancer | 2022 |
| 32768562 | Potentiating Antitumor Efficacy Through Radiation and Sustained Intratumoral Delivery of Anti-CD40 and Anti-PDL1. | Int J Radiat Oncol Biol Phys | 2021 |
| 33827904 | Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose? | J Immunother Cancer | 2021 |
| 33678606 | Differential and longitudinal immune gene patterns associated with reprogrammed microenvironment and viral mimicry in response to neoadjuvant radiotherapy in rectal cancer. | J Immunother Cancer | 2021 |
| 33561212 | The role of radiotherapy in the age of immunotherapy. | Jpn J Clin Oncol | 2021 |
| 33637449 | Liver Metastasis Irradiation Can Restore Immunotherapeutic Responsiveness. | Trends Immunol | 2021 |
| 34408925 | LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells. | Oncoimmunology | 2021 |
| 34078406 | Perspectives in immunotherapy: meeting report from the immunotherapy bridge (December 2nd-3rd, 2020, Italy). | J Transl Med | 2021 |
| 34290243 | 3-hydroxy-L-kynurenamine is an immunomodulatory biogenic amine. | Nat Commun | 2021 |
| 33997267 | Preventive efficacy of a tenofovir alafenamide fumarate nanofluidic implant in SHIV-challenged nonhuman primates. | Adv Ther (Weinh) | 2021 |
| 33476307 | Radiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control. | J Clin Invest | 2021 |
| 33446447 | Targeting Cancer Heterogeneity with Immune Responses Driven by Oncolytic Peptides. | Trends Cancer | 2021 |
| 33093219 | Activin A Promotes Regulatory T-cell-Mediated Immunosuppression in Irradiated Breast Cancer. | Cancer Immunol Res | 2021 |
| 32532811 | Radiotherapy Cooperates with IL15 to Induce Antitumor Immune Responses. | Cancer Immunol Res | 2020 |
| 32047024 | CD73 Blockade Promotes Dendritic Cell Infiltration of Irradiated Tumors and Tumor Rejection. | Cancer Immunol Res | 2020 |
| 31831632 | Aggressive Mammary Cancers Lacking Lymphocytic Infiltration Arise in Irradiated Mice and Can Be Prevented by Dietary Intervention. | Cancer Immunol Res | 2020 |
| 32064049 | Exercise reduces immune suppression and breast cancer progression in a preclinical model. | Oncotarget | 2020 |
| 33072860 | Emerging technologies for local cancer treatment. | Adv Ther (Weinh) | 2020 |
| 33150045 | Converging focal radiation and immunotherapy in a preclinical model of triple negative breast cancer: contribution of VISTA blockade. | Oncoimmunology | 2020 |
| 32934886 | IL15 synergizes with radiotherapy to reprogram the tumor immune contexture through a dendritic cell connection. | Oncoimmunology | 2020 |
| 32819614 | Future of Radiation and Immunotherapy. | Int J Radiat Oncol Biol Phys | 2020 |
| 32894202 | Perspectives in melanoma: meeting report from the "Melanoma Bridge" (December 5th-7th, 2019, Naples, Italy). | J Transl Med | 2020 |
| 32215874 | Immunogenic Cell Death Driven by Radiation-Impact on the Tumor Microenvironment. | Cancer Treat Res | 2020 |
| 32554542 | Radiation-induced Adaptive Response: New Potential for Cancer Treatment. | Clin Cancer Res | 2020 |
| 32209603 | Consensus guidelines for the definition, detection and interpretation of immunogenic cell death. | J Immunother Cancer | 2020 |
| 32129476 | The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice. | J Pathol | 2020 |
| 30650045 | Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers. | J Clin Oncol | 2019 |
| 31752991 | Immune induction strategies to enhance responses to PD-1 blockade: lessons from the TONIC trial. | J Immunother Cancer | 2019 |
| 31416487 | The great debate at "Immunotherapy Bridge 2018", Naples, November 29th, 2018. | J Immunother Cancer | 2019 |
| 31296256 | Baseline T cell dysfunction by single cell network profiling in metastatic breast cancer patients. | J Immunother Cancer | 2019 |
| 31221199 | Radiation therapy and anti-tumor immunity: exposing immunogenic mutations to the immune system. | Genome Med | 2019 |
| 31189943 | Transcriptomic profiles conducive to immune-mediated tumor rejection in human breast cancer skin metastases treated with Imiquimod. | Sci Rep | 2019 |
| 30888406 | Stromal Tumor-infiltrating Lymphocytes in NRG Oncology/NSABP B-31 Adjuvant Trial for Early-Stage HER2-Positive Breast Cancer. | J Natl Cancer Inst | 2019 |